AR023045A2 - Composicion de tiotepa secada por congelacion para administracion parenteral - Google Patents

Composicion de tiotepa secada por congelacion para administracion parenteral

Info

Publication number
AR023045A2
AR023045A2 ARP990104393A ARP990104393A AR023045A2 AR 023045 A2 AR023045 A2 AR 023045A2 AR P990104393 A ARP990104393 A AR P990104393A AR P990104393 A ARP990104393 A AR P990104393A AR 023045 A2 AR023045 A2 AR 023045A2
Authority
AR
Argentina
Prior art keywords
composition
tiotepa
freezing
dried
parenteral administration
Prior art date
Application number
ARP990104393A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR023045A2 publication Critical patent/AR023045A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion liofilizada estable del agente alquilante antitumoral tiotepa y un método para preparar dicha composicion a través de la co-liofilizaciondel ingrediente activo con un agente alcalinizante farmacéuticamente aceptable
ARP990104393A 1993-11-09 1999-09-01 Composicion de tiotepa secada por congelacion para administracion parenteral AR023045A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15050193A 1993-11-09 1993-11-09

Publications (1)

Publication Number Publication Date
AR023045A2 true AR023045A2 (es) 2002-09-04

Family

ID=22534834

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104393A AR023045A2 (es) 1993-11-09 1999-09-01 Composicion de tiotepa secada por congelacion para administracion parenteral

Country Status (29)

Country Link
US (1) US5561121A (es)
EP (1) EP0656211B1 (es)
JP (1) JP3726255B2 (es)
KR (1) KR100348382B1 (es)
CN (1) CN1111130A (es)
AR (1) AR023045A2 (es)
AT (1) ATE180670T1 (es)
AU (1) AU690143B2 (es)
CA (1) CA2135265A1 (es)
CZ (1) CZ287052B6 (es)
DE (1) DE69418832T2 (es)
DK (1) DK0656211T3 (es)
ES (1) ES2133152T3 (es)
FI (1) FI116036B (es)
GR (1) GR3031122T3 (es)
HK (1) HK1011283A1 (es)
HU (1) HU218216B (es)
IL (1) IL111534A (es)
NO (1) NO305274B1 (es)
NZ (1) NZ264861A (es)
PE (1) PE22995A1 (es)
PH (1) PH31219A (es)
PL (1) PL176984B1 (es)
RU (1) RU2134112C1 (es)
SG (1) SG63584A1 (es)
SI (1) SI0656211T1 (es)
SK (1) SK280840B6 (es)
TW (1) TW344662B (es)
ZA (1) ZA948833B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726343D0 (en) * 1997-12-13 1998-02-11 Auffret Anthony The use of excipients to accelerate freeze-drying
CA2449593A1 (en) * 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
EP2889029A1 (en) 2008-09-25 2015-07-01 Cephalon, Inc. Liquid formulations of bendamustine
BRPI1004922A2 (pt) 2009-01-15 2019-09-24 Cephalon Inc composição farmacêutica, forma cristalina da base livre de bendamustina e método de tratamento de leucemia linfocítica crônica, doença de hodgkin, linfoma não-hodgkin, mieloma múltiplo ou câncer da mama
CA2850513A1 (en) * 2011-09-29 2013-04-04 Janssen Pharmaceutica Nv Process for the preparation of sulfamide derivatives
CN104349417B (zh) * 2013-08-07 2017-11-21 中国科学院声学研究所 基于短生命周期的区域性水下通信网的组网方法
WO2018227112A1 (en) 2017-06-09 2018-12-13 The Trustees Of Columbia University In The City Of New York Short tat oligomers for drug delivery
CN109956972A (zh) * 2017-12-22 2019-07-02 四川科瑞德凯华制药有限公司 塞替派晶型i及其制备方法和用途
CN110917146A (zh) * 2019-12-03 2020-03-27 黑龙江福和制药集团股份有限公司 一种塞替派粉针及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2670347A (en) * 1952-01-08 1954-02-23 American Cyanamid Co Thiophosphoric acid derivatives and method of preparing the same
GB845823A (en) * 1957-09-19 1960-08-24 Sumitomo Chemical Co Stabilised compositions comprising therapeutic imine derivatives and the preparation thereof
DE1951822C3 (de) * 1969-10-14 1980-12-11 Kowa Co., Ltd., Nagoya, Aichi (Japan) Pharmazeutisches Präparat zur Krebsbehandlung
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
EP0120907A1 (en) * 1982-10-13 1984-10-10 Aston Molecules Limited Pharmaceutical preparations for use in antitumour therapy
EP0140255B1 (en) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
CH676508A5 (es) * 1986-10-13 1991-01-31 Anawa Lab Ag
US4918199A (en) * 1988-01-21 1990-04-17 American Cyanamid Company Process for producing thiotepa
US5122367A (en) * 1989-03-31 1992-06-16 Massachusetts Institute Of Technology Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone
EP0419890A3 (en) * 1989-09-29 1991-05-29 American Cyanamid Company Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method

Also Published As

Publication number Publication date
JP3726255B2 (ja) 2005-12-14
ES2133152T3 (es) 1999-09-01
CN1111130A (zh) 1995-11-08
KR100348382B1 (ko) 2002-11-23
NO305274B1 (no) 1999-05-03
DE69418832T2 (de) 1999-09-23
EP0656211B1 (en) 1999-06-02
HU9403210D0 (en) 1995-01-30
IL111534A0 (en) 1995-01-24
IL111534A (en) 1999-06-20
JPH07196517A (ja) 1995-08-01
HK1011283A1 (en) 1999-07-09
NZ264861A (en) 1995-10-26
US5561121A (en) 1996-10-01
FI116036B (fi) 2005-09-15
HUT70762A (en) 1995-10-30
AU690143B2 (en) 1998-04-23
EP0656211A1 (en) 1995-06-07
PL305752A1 (en) 1995-05-15
SK280840B6 (sk) 2000-08-14
PH31219A (en) 1998-05-05
NO944256L (no) 1995-05-10
SG63584A1 (en) 1999-03-30
PE22995A1 (es) 1995-09-08
CZ271894A3 (en) 1995-07-12
TW344662B (en) 1998-11-11
AU7768994A (en) 1995-05-18
HU218216B (hu) 2000-06-28
FI945252A0 (fi) 1994-11-08
DK0656211T3 (da) 1999-11-15
CA2135265A1 (en) 1995-05-10
NO944256D0 (no) 1994-11-08
RU2134112C1 (ru) 1999-08-10
RU94040150A (ru) 1996-09-20
CZ287052B6 (en) 2000-08-16
ZA948833B (en) 1995-07-14
SK135294A3 (en) 1996-01-10
PL176984B1 (pl) 1999-08-31
ATE180670T1 (de) 1999-06-15
GR3031122T3 (en) 1999-12-31
FI945252A (fi) 1995-05-10
SI0656211T1 (en) 1999-08-31
DE69418832D1 (de) 1999-07-08

Similar Documents

Publication Publication Date Title
AR002355A1 (es) Composiciones y metodos para administracion local de agentes farmaceuticamente activos.
AR023045A2 (es) Composicion de tiotepa secada por congelacion para administracion parenteral
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
PL335571A1 (en) Stabilisation of acid-sensitive benzimidazoles by combining them with amino acids and cyclodextrins
MY129356A (en) Electrospun pharmaceutical compositions
HK1008294A1 (en) (2-4-Disulfophenyl) n-tertiary butyl nitrone its salts and their use as pharmaceutical radical trapping agents
TR199501599A2 (tr) 17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri.
GEP20053473B (en) High Potency Dihydroergotamine Compositions
BR9604880A (pt) Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
ES2162927T3 (es) Formulacion para la aplicacion por inhalacion.
EP0830369A4 (en) NOR-PREGNANE FOR INDUCING HYPOTHALAMIC EFFECTS
CO4900022A1 (es) Composicion topica y metodo para incrementar la sintesis de la barrera del lipido la barrera de lipido utilizando dicha composicion
MY113203A (en) Lyophilizate of lipid complex of water insoluble camptothecins
AR019699A1 (es) Composicion farmaceutica para el tratamiento de disfuncion de la evacuacion y uso de la misma para la preparacion de un agente terapeutico
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
AP2002002652A0 (en) The use of azalide antibiotic composition for treating or preventing a bacterial or protozoal infection in mammals.
MY124465A (en) Reduction of infarct volume using citicoline
ES2008420A6 (es) Procedimiento de obtencion de un preparado seco adecuado para la fabricacion de una suspension acuosa de una sal de diclofenac
HRP20020258B1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
ES2194899T3 (es) Composicion farmaceutica para administracion transdermica sistemica del principio activo morfina-6-glucuronido.
ES2184121T3 (es) Formulacion para el tratamiento y/o profilaxis de la demencia.
AR010344A1 (es) Uso de equilenina o una sal farmaceuticamente aceptable del ester de equilenina-3-sulfato para la manufactura de un medicamento util para inhibir otratar patologias inducidas por los radicales libres y composiciones farmaceuticas
CA2336773A1 (en) Component b as angiogenic agent in combination with human growth factors
WO1998034598A3 (en) Homogeneous granulated formulations for dose sipping technology